Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture

Blood Pressure

Volumn 6, Issue 1, 1997, Pages 24-28

  Saijonmaa, Outi ^a   Metsärinne, Kaj ^a,b   Fyhrquist, Frej ^a,b  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

carvedilol; carvedilol metabolites; endothelin 1; HUVEC

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARVEDILOL; DRUG METABOLITE; ENDOTHELIN 1; INDOMETACIN; METOPROLOL; N(G) NITROARGININE METHYL ESTER; NICARDIPINE; PRAZOSIN; PROBUCOL; PROPRANOLOL;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; UMBILICAL CORD;

EID: 0031015697     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059709086442     Document Type: Article

References (21)

1. Packer M, Bristow M, Cohn J, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
2. McTavish D, Campoli-Richards D, Sorkin E. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1993; 45: 232-58.
3. Ohlstein E, Douglas S, Sung C, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci USA 1993; 90: 6189-93.
4. Ohlstein E, Vickery L, Arleth A, et al. Carvedilol, a novel cardiovascular agent, inhibits development of vascular and ventricular hypertrophy in spontaneously hypertensive rats. Clin Exp Hypertens 1994; 16: 163-77.
5. Yue T, Mckenna P, Gu J-L, Cheng H, Ruffolo R, Feuerstein G. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. Hypertension 1993; 22: 922-8.
6. Yue T, McKenna P, Gu J, Cheng H, Ruffolo R, Feuerstein G. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovasc Res 1994; 28: 400-6.
7. Lopez B, Christopher T, Yue T, Ruffolo R, Feuerstein G, Ma X. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology 1995; 51: 165-73.
8. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
9. Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev 1992; 12: 391-421.
10. Krum H, Gu A, Wilshire-Clement M, et al. Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure. Am Heart J 1996; 131: 337-41.
11. Jaffe E, Nachman R, Becker C, Minick R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologie criteria. J Clin Invest 1973; 52: 2745-56.
12. Fyhrquist F, Saijonmaa O, Metsärinne K, Tikkanen I, RosenlÖf K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun 1990; 169: 217-21.
13. Ruffolo R, Jr, Boyle D, Venuit R, Lukas M. Carvedilol (kredex): a novel multiple action cardiovascular agent. Drugs Today 1991; 27: 465-92.
14. Louis W, Mcnell J, Workman B, Drummer O, Conway E. A pharmacokinetic study of carvedilol (BM 14190) in elderly subjects: Preliminary report. J Cardiovasc Pharmacol 1987; 10: S89-93.
15. Yue T-L, Mckenna P, Lysko P, Gu J-L, Lysko K, Ruffolo R, Jr, Feuerstein G. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J Pharmacol 1994; 251: 237-43.
16. Emori T, Hirata Y, Ohta K, Shichiri M, Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989; 160: 93-100.
17. Yue T-L, Mckenna P, Lysko P, Ruffolo R, Jr, Feuerstein G. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper. Atherosclerosis 1992; 97: 209-16.
18. Feuerstein R, Yue T-L. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity. Pharmacology 1994; 48: 385-91.
19. Boulanger C, Lüscher T. Release of endothelin from porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-90.
20. Saijonmaa O, Ristimäki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990; 173: 514-20.
21. Yokokawa K, Kohno M, Yasunari K, Murakawa K, Takeda, T. Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension 1991; 18:304-15.